ESR1 and breast cancer: The evidence that PAK1 phosphorylates S305 [19] was indirect and was not confirmed by a direct inspection of the phosphorylation of ERα Ser305 using specific antibodies or by the introduction of a dominant-active PAK1 into breast cancer cells [44].